Alyssa Johnsen

Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis

Annals of the Rheumatic Diseases · 2017 · 179 citations

Impact of baseline anti-cyclic citrullinated peptide-2 antibody concentration on efficacy outcomes following treatment with subcutaneous abatacept or adalimumab: 2-year results…

Annals of the Rheumatic Diseases · 2016 · 156 citations